CSI Market
Sign In | Register

Flexion Therapeutics Inc (FLXN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access FLXN quarterly Cash Flow →
Cash flow patterns shown here provide context for understanding Flexion Therapeutics Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
12 Months 		(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Operating Activities
Income-113.71
Depreciation & amortization1.70
Amortization of Other Assets9.37
Increase (Decrease) in Deferred Revenue10.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase1.62
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.26
Share-based Compensation18.58
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Operating Lease Right Of Use Asset Amortization1.65
Non Cash Interest Expense0.74
Premium Paid On Securities Purchased-0.73
Increase Decrease In Operating Lease Liability-1.31
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable7.09
Increase (Decrease) in Accounts Payable, Trade-6.56
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.27
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.26
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.21
Discontinued operations0.00
Net Cash flow from Operating Activities-70.56
Investing Activities
Capital Expenditures-10.07
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities66.90
Payments to Acquire Marketable Securities-79.62
Real Estate Investments0.00
Discount Received On Securities Purchased-
Payments To Proceeds From Acquired Marketable Securities-
Proceeds From Sale Of Fixed Assets0.03
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-22.76
Financing Activities
Short-term debt Net-15.00
Other borrowing transactions0.00
Long-term debt - borrowings15.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock98.78
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Convertible Debt Gross-
Proceeds From Revolving Line Of Credit20.00
Proceeds From The Offering Of Common Stock-
Payment Proceeds From Stock Options Exercised-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities118.78
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-80.63
Total Cash Flow25.45
4 historic quarters locked

Sign in to unlock the full Flexion Therapeutics Inc cash flow history.

Sign In Create Free Account

About FLXN Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License